Summary
Updated Aug 31, 2026
Richard Mulligan files SEC Form 4 reports at Sana Biotechnology, Inc. (SANA). 3 SEC Form 4 filings on record going back to 2025, most recently on 5 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Richard Mulligan has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Richard Mulligan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Roelof Botha - $34.89M of NTRA open-market activity in the last 12 months
- Nello Mainolfi - $34.88M of KYMR open-market activity in the last 12 months
- James C. Foster - $34.84M of CRL open-market activity in the last 12 months
- Third Rock Ventures V, L.P. - $34.39M of RAPP open-market activity in the last 12 months
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard Mulligan?
Richard Mulligan is a corporate insider of Sana Biotechnology, Inc. (SANA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard Mulligan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Richard Mulligan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard Mulligan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
